$CCTSF Cashflow Statement | Understand Stock

$CCTSF

$11.01 -$0.78 (6.62%) Close

$CCTSF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 8 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the year
Adjustments to reconcile net loss to net cash used in operating activities:
Financial expenses
Changes in operating assets and liabilities:
Stock based compensation
Decrease (increase) in prepaid expenses
Decrease in related parties
Increase (decrease) in accrued expenses
Increase in accrued expenses
Net cash (used in), operating activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of Class B Ordinary Shares
Proceeds from issuance of public units
Proceeds from issuance of Private warrants
Payment of underwriting commissions and offering expenses
Proceeds from a promissory note – related party
Repayment of promissory note – related party
Redemption of Class A Ordinary shares
Proceeds from sponsor loan
Proceeds from promissory note
Net cash (used in), financing activities
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE PERIOD
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE PERIOD
Cash and cash equivalents
Cash held in trust account
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH:
Cash and cash equivalents
Cash held in trust account
Underwriters’ Deferred Compensation
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD

SUPPLEMENTARY INFORMATION ON INVESTING AND FINANCING ACTIVITIES NOT INVOLVING CASH FLOWS:
Sponsor Loan Waiver
Sponsor inducement for issuing the promissory note
Underwriters’ deferred compensation waiver

Comments